Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials.
Changsong QiPanpan ZhangChang LiuJun ZhangJun ZhouJiajia YuanDan LiuMiao ZhangJifang GongXicheng WangJian LiXiaotian ZhangNing LiXiaohui PengZhen LiuDaijing YuanRaffaele BaffaYumeng WangLin ShenPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
In patients with metastatic PC after progression on previous therapy, CT041 demonstrated a tolerable safety profile and encouraging anticancer efficacy signals. Response benefit observed here needs to be ascertained in the future.